• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,947.72 -10.80
( -0.01%)
Global Indices
Nasdaq
49,922.52 603.26
(1.22%)
Dow Jones
7,387.39 107.17
(1.47%)
Hang Seng
62,916.52 3,403.40
(5.72%)
Nikkei 225
10,442.09 222.98
(2.18%)
Forex
USD-INR
95.18 0.09
(0.09%)
EUR-INR
111.29 -0.04
(-0.04%)
GBP-INR
128.89 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(-0.23%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
17.34
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
299
68.4
EPS(TTM)
Face Value()
Div & Yield %
0.15
10
0
 

hcl technologies ltd
IT pack tumbles as weak guidance from HCL Tech spooks markets
Apr 22,2026
The Nifty IT index dropped 4.12% to 30,422. Shares of HCL Technologies 10.60%. Tech Mahindra declined 5.57%, Coforge dropped 5.40% and Persistent Systems slipped 4.59%. Infosys fell 4.17%, while L&T Technology Services declined 3.34% and TCS lost 2.78%. Mphasis fell 2.32%, while Wipro saw a relatively smaller decline of 0.83%.

The selloff followed HCL Tech's FY27 revenue growth guidance of 1% to 4% in constant currency, which came below market expectations. The company cited weak discretionary spending, delays in client decision-making and project ramp-downs.

Its Q4 performance also disappointed, with revenue and profit missing estimates and new deal bookings falling to a three-quarter low.

The weakness spread across the sector as investors took the company’s outlook as an indicator for peers, given the heavy dependence of Indian IT firms on global markets.

Market participants are now closely watching upcoming earnings from other IT majors for further cues on demand trends and growth outlook.